MEDIROM Healthcare Technologies Inc. to acquire Japan Gene Medicine Corporation for business expansion
Acquiring Company
MEDIROM Healthcare Technologies
Acquired Company
Japan Gene Medicine Corporation
Minato CityChiyodaSoftwareHealth CareBiotechnologyHealth CareMedicalDescription
MEDIROM Healthcare Technologies Inc. has announced the execution of a Memorandum of Understanding to acquire all shares of Japan Gene Medicine Corporation and make it a subsidiary, with the aim of synergizing their health management and prenatal diagnosis businesses. This acquisition aligns with MEDIROM’s strategy of expanding its presence in Japan and becoming a comprehensive healthcare general trading company.
Quick answer
MEDIROM Healthcare Technologies is acquiring Japan Gene Medicine Corporation, announced April 3, 2024. MEDIROM Healthcare Technologies is based in Minato City, Tokyo, Japan.
- How much did MEDIROM Healthcare Technologies pay for Japan Gene Medicine Corporation?
- The deal value was not disclosed.
- What does MEDIROM Healthcare Technologies do?
- MEDIROM MOTHER Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc. dedicated to global challenges and the development of the MOTHER Bracelet, a recharge-free smart tracker designed to monitor people's..
- Where are MEDIROM Healthcare Technologies and Japan Gene Medicine Corporation based?
- MEDIROM Healthcare Technologies is based in Minato City, Tokyo, Japan. Japan Gene Medicine Corporation is based in Chiyoda, Tokyo, Japan.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Software
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
- Integrated Oncology Network completes acquisition of Urology Partners, LLC to expand urologic healthcare services (May 2, 2024)
Who to call at MEDIROM Healthcare Technologies, and when
When MEDIROM Healthcare Technologies changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day MEDIROM Healthcare Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MEDIROM Healthcare Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MEDIROM Healthcare Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MEDIROM Healthcare Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Japan Gene Medicine Corporation?
Japan Gene Medicine Corporation was acquired by MEDIROM Healthcare Technologies, based in Minato City. The deal was reported on April 3, 2024. MEDIROM MOTHER Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc. MEDIROM Healthcare Technologies is publicly traded (MRM) and operates in Software.
When did MEDIROM Healthcare Technologies acquire Japan Gene Medicine Corporation?
MEDIROM Healthcare Technologies's acquisition of Japan Gene Medicine Corporation was reported on April 3, 2024. MEDIROM Healthcare Technologies Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Japan Gene Medicine Corporation do?
Japan Gene Medicine Corporation is engaged in prenatal diagnosis business providing genetic testing and analysis services, with a focus on the target demographic of women in their 20s to 40s. It is privately held, operating in Biotechnology, and is based in Chiyoda.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.